WuXi in deal to develop Vir’s antibody against coronavirus
Vir Biotechnology turns to WuXi to support development and commercialization of an antibody-based potential treatment for the coronavirus.
Archives for February 27, 2020
Biocon insulin facility hit with FDA Form 483
Biocon’s Malaysia facility received a Form 483 with three observations, after a pre-approval inspection.
Securecell extends reach in Asia, Israel
The biopharma solutions firm is expanding its footprint with new sales and marketing partners in China, Korea and Israel.
Frontage continues build-out to meet late-stage developers demand
Frontage has announced completion of its Pennsylvania site expansion to boost its offering of bioanalytical services for late-stage cell and gene therapies developers.